Cargando…

The Efficacy of New Chinese Diabetes Risk Score in Screening Undiagnosed Type 2 Diabetes and Prediabetes: A Community-Based Cross-Sectional Study in Eastern China

The New Chinese Diabetes Risk Score (NCDRS) is one of the recommended tools for screening undiagnosed type 2 diabetes in China. However, its performance in detecting undiagnosed diabetes needs to be verified in different community populations. Also, it is unknown whether NCDRS can be used in detecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Tao, Chen, Jiayan, Guo, Haijian, Qu, Chen, He, Chu, Xu, Xuepeng, Yang, Guoping, Zhen, Shiqi, Li, Xiaoning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210548/
https://www.ncbi.nlm.nih.gov/pubmed/32405505
http://dx.doi.org/10.1155/2020/7463082
_version_ 1783531296187744256
author Mao, Tao
Chen, Jiayan
Guo, Haijian
Qu, Chen
He, Chu
Xu, Xuepeng
Yang, Guoping
Zhen, Shiqi
Li, Xiaoning
author_facet Mao, Tao
Chen, Jiayan
Guo, Haijian
Qu, Chen
He, Chu
Xu, Xuepeng
Yang, Guoping
Zhen, Shiqi
Li, Xiaoning
author_sort Mao, Tao
collection PubMed
description The New Chinese Diabetes Risk Score (NCDRS) is one of the recommended tools for screening undiagnosed type 2 diabetes in China. However, its performance in detecting undiagnosed diabetes needs to be verified in different community populations. Also, it is unknown whether NCDRS can be used in detecting prediabetes. In the present study, we aimed to evaluate the performance of NCDRS in detecting undiagnosed diabetes and prediabetes among the community residents in eastern China. We applied NCDRS in 7675 community residents aged 18-65 years old in Jiangsu Province. The results showed that the participants with undiagnosed diabetes reported the highest NCDRS value, followed by those with prediabetes (P < 0.001). The best cut-off points of NCDRS for detecting undiagnosed diabetes and prediabetes were 27 (with a sensitivity of 78.0% and a specificity of 57.7%) and 27 (with a sensitivity of 66.0% and a specificity of 62.9%). The AUCs of NCDRS for identifying undiagnosed diabetes and prediabetes were 0.749 (95% CI: 0.739~0.759) and 0.694 (95% CI: 0.683~0.705). These results demonstrate the excellent performance of NCDRS in screening undiagnosed diabetes in the community population in eastern China and further provide evidence for using NCDRS in detecting prediabetes.
format Online
Article
Text
id pubmed-7210548
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-72105482020-05-13 The Efficacy of New Chinese Diabetes Risk Score in Screening Undiagnosed Type 2 Diabetes and Prediabetes: A Community-Based Cross-Sectional Study in Eastern China Mao, Tao Chen, Jiayan Guo, Haijian Qu, Chen He, Chu Xu, Xuepeng Yang, Guoping Zhen, Shiqi Li, Xiaoning J Diabetes Res Research Article The New Chinese Diabetes Risk Score (NCDRS) is one of the recommended tools for screening undiagnosed type 2 diabetes in China. However, its performance in detecting undiagnosed diabetes needs to be verified in different community populations. Also, it is unknown whether NCDRS can be used in detecting prediabetes. In the present study, we aimed to evaluate the performance of NCDRS in detecting undiagnosed diabetes and prediabetes among the community residents in eastern China. We applied NCDRS in 7675 community residents aged 18-65 years old in Jiangsu Province. The results showed that the participants with undiagnosed diabetes reported the highest NCDRS value, followed by those with prediabetes (P < 0.001). The best cut-off points of NCDRS for detecting undiagnosed diabetes and prediabetes were 27 (with a sensitivity of 78.0% and a specificity of 57.7%) and 27 (with a sensitivity of 66.0% and a specificity of 62.9%). The AUCs of NCDRS for identifying undiagnosed diabetes and prediabetes were 0.749 (95% CI: 0.739~0.759) and 0.694 (95% CI: 0.683~0.705). These results demonstrate the excellent performance of NCDRS in screening undiagnosed diabetes in the community population in eastern China and further provide evidence for using NCDRS in detecting prediabetes. Hindawi 2020-04-29 /pmc/articles/PMC7210548/ /pubmed/32405505 http://dx.doi.org/10.1155/2020/7463082 Text en Copyright © 2020 Tao Mao et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mao, Tao
Chen, Jiayan
Guo, Haijian
Qu, Chen
He, Chu
Xu, Xuepeng
Yang, Guoping
Zhen, Shiqi
Li, Xiaoning
The Efficacy of New Chinese Diabetes Risk Score in Screening Undiagnosed Type 2 Diabetes and Prediabetes: A Community-Based Cross-Sectional Study in Eastern China
title The Efficacy of New Chinese Diabetes Risk Score in Screening Undiagnosed Type 2 Diabetes and Prediabetes: A Community-Based Cross-Sectional Study in Eastern China
title_full The Efficacy of New Chinese Diabetes Risk Score in Screening Undiagnosed Type 2 Diabetes and Prediabetes: A Community-Based Cross-Sectional Study in Eastern China
title_fullStr The Efficacy of New Chinese Diabetes Risk Score in Screening Undiagnosed Type 2 Diabetes and Prediabetes: A Community-Based Cross-Sectional Study in Eastern China
title_full_unstemmed The Efficacy of New Chinese Diabetes Risk Score in Screening Undiagnosed Type 2 Diabetes and Prediabetes: A Community-Based Cross-Sectional Study in Eastern China
title_short The Efficacy of New Chinese Diabetes Risk Score in Screening Undiagnosed Type 2 Diabetes and Prediabetes: A Community-Based Cross-Sectional Study in Eastern China
title_sort efficacy of new chinese diabetes risk score in screening undiagnosed type 2 diabetes and prediabetes: a community-based cross-sectional study in eastern china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210548/
https://www.ncbi.nlm.nih.gov/pubmed/32405505
http://dx.doi.org/10.1155/2020/7463082
work_keys_str_mv AT maotao theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina
AT chenjiayan theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina
AT guohaijian theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina
AT quchen theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina
AT hechu theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina
AT xuxuepeng theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina
AT yangguoping theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina
AT zhenshiqi theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina
AT lixiaoning theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina
AT maotao efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina
AT chenjiayan efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina
AT guohaijian efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina
AT quchen efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina
AT hechu efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina
AT xuxuepeng efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina
AT yangguoping efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina
AT zhenshiqi efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina
AT lixiaoning efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina